Phase 3 PROPEL 3 data published today in NEJM were simultaneously presented at ICCBH in a late-breaking oral presentation; presentation includes new arm span Z-score data showing a statistically ...

AP-101 is an investigational human-derived antibody that selectively targets the misfolded, toxic form of superoxide dismutase 1 (SOD1) to disrupt the progressive spread of ALS. The goal of this ...

Oxylabs explores how fresh web data infrastructure helps AI systems reduce hallucinations and deliver accurate real-world ...

An alarming number of young people are turning away from the news according to the Reuters Digital News Report presented at ...

A good software architecture ensures that an AI system does not depend on the performance of a specific model.

Qualcomm QCOM-Q said it expects to generate US$15-billion in sales from its data centre business by 2029 as it moves beyond ...

If you receive JavaScript required to sign in error message when using Skype, OneDrive, Teams or any other program, you need to turn on or enable JavaScript in your ...

Scouring through corporate communications and broker research isn’t enough Daniel Liberto is a journalist with over 10 years of experience working with publications such as the Financial Times, The ...

At the recent Google Marketing Live event, the search engine described how their data was showing that AI-powered search is ...

CHICAGO and FORT WORTH, Texas, June 01, 2026 (GLOBE NEWSWIRE) -- Actuate Therapeutics, Inc. (NASDAQ: ACTU), a clinical-stage biopharmaceutical company focused on developing novel therapies for ...

Marea Therapeutics, Inc., a clinical-stage biotechnology company harnessing the latest advances in human genetics to develop first-in-class, next-generation medicines for cardioendocrine diseases, ...

Doug Wintemute is a staff writer for Forbes Advisor. After completing his master’s in English at York University, he began his writing career in the higher education space. Over the past decade, Doug ...